Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$113.32 - $241.49 $350,952 - $747,894
-3,097 Closed
0 $0
Q1 2021

May 06, 2021

SELL
$85.73 - $119.5 $288,395 - $401,998
-3,364 Reduced 52.07%
3,097 $338,000
Q4 2020

Feb 01, 2021

BUY
$72.71 - $129.54 $77,654 - $138,348
1,068 Added 19.8%
6,461 $526,000
Q3 2020

Oct 29, 2020

BUY
$57.81 - $104.17 $311,769 - $561,788
5,393 New
5,393 $373,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $19.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Harvest Investment Services, LLC Portfolio

Follow Harvest Investment Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Investment Services, LLC with notifications on news.